Clorox (NYSE:CLX) Given New $125.00 Price Target at Wells Fargo & Company

Clorox (NYSE:CLX) had its price target decreased by Wells Fargo & Company from $130.00 to $125.00 in a report published on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

A number of other analysts have also commented on CLX. Barclays dropped their price target on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research note on Tuesday, July 15th. Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. Citigroup reissued a “neutral” rating and set a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. JPMorgan Chase & Co. raised their price objective on Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. Finally, UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research report on Thursday, July 17th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average target price of $141.73.

Clorox Stock Performance

Shares of CLX stock opened at $122.76 on Thursday. The stock has a fifty day moving average of $123.61 and a 200 day moving average of $130.63. Clorox has a 52 week low of $116.53 and a 52 week high of $171.37. The firm has a market capitalization of $15.01 billion, a price-to-earnings ratio of 18.83, a PEG ratio of 0.99 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same quarter last year, the firm posted $1.82 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts expect that Clorox will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.57% of the stock is owned by insiders.

Hedge Funds Weigh In On Clorox

Several institutional investors and hedge funds have recently modified their holdings of CLX. Total Investment Management Inc. bought a new position in shares of Clorox during the second quarter valued at $25,000. American National Bank & Trust increased its holdings in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. NewSquare Capital LLC increased its holdings in Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after buying an additional 193 shares in the last quarter. Darwin Wealth Management LLC bought a new stake in Clorox in the 2nd quarter worth about $29,000. Finally, Wood Tarver Financial Group LLC bought a new stake in Clorox in the 4th quarter worth about $31,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.